Labshake search
Citations for Peprotech :
1851 - 1900 of 2186 citations for FGF 7 Keratinocyte Growth Factor Human 163a.a since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... in the presence of human recombinant M-CSF (100 ng/µL; Peprotech). Blood donors provided written informed consent for the collection of samples and subsequent analysis ...
-
bioRxiv - Cell Biology 2021Quote: ... recombinant human IL-6 (10 ng/mL) (Peprotech, Cat#AF-200-06) and where applicable ...
-
bioRxiv - Immunology 2021Quote: ... cells were cultured with recombinant human IL-21 (100 ng/mL; Peprotech) and either with ...
-
bioRxiv - Bioengineering 2022Quote: ... and recombinant human basic fibroblast GF (bFGF) were purchased from PeproTech (USA). The bFGF ELISA Kit was purchased from MultiSciences (Hangzhou ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of recombinant human IL-2 (50 U/ml, Peprotech) for 3 days ...
-
bioRxiv - Cell Biology 2022Quote: ... 1X-penicillin/streptomycin and human recombinant BMP-2 (100 ng/ml, Peprotech).16 Chondrogenic media and growth factor were changed every other day until the end of 21 days of chondrogenic differentiation ...
-
bioRxiv - Cancer Biology 2023Quote: Recombinant Human TNF-α (Cat #300-01A, PeproTech, Rocky Hill, NJ, USA) and Recombinant Human IFN-γ (Cat # 300-02 ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with 100 ng/ml human recombinant M-CSF (Peprotech, 300-25) for 7 days ...
-
bioRxiv - Cancer Biology 2023Quote: ... 50 or 200 ng/mL of human recombinant BMP2 (Peprotech, 120-02C). Media were renewed twice a week ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 10 ng/mL recombinant human erythropoietin (EPO, Peprotech, Cranbury, NJ, USA), in a humidified incubator maintained at 37°C under 5% CO2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech; #AF-100-15), 10 ng/ml Recombinant Human FGF-basic (Peprotech ...
-
bioRxiv - Genetics 2023Quote: ... and 5 ng/ml of recombinant human IL-3 (PEPROTECH, 200-03). During days 7-11 of culture in EDM-2 ...
-
bioRxiv - Immunology 2023Quote: ... 20 ng/mL recombinant human TGF-β1 (PeproTech, Cat no. 100-21), and 30 ng/mL recombinant murine GM-CSF (PeproTech ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 ng/mL Human GM-CSF (Peprotech; Cat. No. 300-03). Two days later ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 40 ng/mL recombinant human EGF (Peprotech, 236-EG-200) 40ng/mL recombinant human FGF (R&D systems ...
-
bioRxiv - Cancer Biology 2023Quote: ... 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech; #AF-100-15), 10 ng/ml Recombinant Human FGF-basic (Peprotech ...
-
bioRxiv - Cancer Biology 2022Quote: ... and the human TGF-β (5 ng/mL) was added (Peprotech, Spain) for 48 hours ...
-
bioRxiv - Immunology 2023Quote: ... Both in vitro conditions received 10U/ml recombinant human IL-2 (Peprotech) at days 2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... following by stimulation of human TNFα (10 ng/ml; Peprotech, 300-01A) for 8 h.
-
bioRxiv - Immunology 2023Quote: ... or 5 ng/mL recombinant human sCD40 Ligand (Peprotech, 310-02-10), 27.5 ug/ml poly I:C (Invivogen ...
-
bioRxiv - Microbiology 2023Quote: ... cells were pre-treated with indicated concentrations or recombinant human IFNβ (Peprotech) for 18h before infection ...
-
bioRxiv - Immunology 2023Quote: ... 1000 IU/mL recombinant (r) human (h) IL-2 (200-02, PeproTech), and 10 ng/mL rhIL-15 (200-15 ...
-
bioRxiv - Biochemistry 2024Quote: ... and 5 ng/ml of recombinant human IL-3 (PEPROTECH, 200-03). During days 7-11 of culture ...
-
bioRxiv - Cell Biology 2024Quote: ... 20 ng/ml recombinant human heregulin β-1 (HRG) (PeproTech, 100-03). Small molecules ...
-
bioRxiv - Cell Biology 2023Quote: ... or with 10 ng/mL of human TGFβ1 (Peprotech; Catalogue#100-21). At the experimental end point at 6 d ...
-
bioRxiv - Genomics 2024Quote: ... 25 ng/ml Recombinant Human IL-3 (Peprotech, catalog no. 200-03)) to allow them to attach ...
-
bioRxiv - Immunology 2024Quote: ... cells were stimulated in the presence of human IL2 (100u/ml, PeproTech), human TGF² (10ng/ml ...
-
bioRxiv - Immunology 2024Quote: ... 50 ng/ml recombinant human M-CSF (PeproTech, Rocky Hill, NJ, USA), 100 U/ml penicillin ...
-
bioRxiv - Immunology 2022Quote: ... CD14+ cells were incubated for 6 days in the presence of 50 ng/ml granulocyte-macrophage colony- stimulating factor (GM-CSF) and 20 ng/ml interleukin-4 (IL-4) (PeproTech®, Neuilly sur Seine, France). The medium used for culture was RPMI ...
-
bioRxiv - Developmental Biology 2021Quote: ... the SC solution was centrifuged at 300 g for 5 minutes to remove the supernatant and SFM containing 50 μg/ml stem cell factor (PeproTech, 300-07, Cranbury, NJ, USA), 100 μg/ml IL-3 (PeproTech ...
-
bioRxiv - Immunology 2021Quote: Both Lin-CD25+CD44- DN3 cells and Lin-CD25-CD44- DN4 cells were sorted from the thymi of LckCre+Zfp335+/+ and LckCre+Zfp335fl/fl mice and co-cultured with OP9-DL1 feeder cells in α-MEM medium in the presence of IL-7 (1 ng/ml, PeproTech) and Flt3-L (5 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... and differentiated for 7 days in Iscove’s Modified Dulbecco’s Media (IMDM) supplemented with 20 ng/ml of M-CSF (Peprotech, Rocky Hill, NJ), 10% heat-inactivated fetal bovine serum (FBS ...
-
bioRxiv - Immunology 2024Quote: ... A single round of co-sedimentation with retroviral stock was performed in medium containing 5% WEHI-3B-conditioned medium and 10 ng/mL IL-7 (Peprotech, USA). After transduction ...
-
bioRxiv - Neuroscience 2021Quote: ... or in combination with 25 ng of human recombinant BDNF (Peprotech, 450-02) or 25 ng of human recombinant GDNF (Peprotech ...
-
bioRxiv - Genomics 2020Quote: ... and treated for 16h with 1 ng/mL recombinant human Interferon gamma (Peprotech). After 16h ...
-
bioRxiv - Bioengineering 2019Quote: ... or TexMACS (Miltentyi Biotech) supplemented with 400 U/mL recombinant human IL2 (Peprotech). Cell cultures were expanded for 14 d as counted from the time of initial seeding and activation ...
-
bioRxiv - Immunology 2021Quote: ... 25 ng/mL recombinant human IL-3 (rhIL-3, PeproTech, Rocky Hill, NJ), and 100 ng/mL recombinant human M-CSF (rhM-CSF ...
-
bioRxiv - Immunology 2021Quote: ... Cells were stimulated for 2h with media or recombinant human IL-33 (Peprotech). Cells were then placed on ice ...
-
bioRxiv - Bioengineering 2021Quote: ... 100 ng mL−1 of recombinant human GDF-15 (120-28C; PeproTech®), and 2 µM of A83-01 (9001799 ...
-
bioRxiv - Immunology 2021Quote: ... supplemented with 35 ng/ml human IL-2 (Peprotech, Cat no. 200-02).
-
bioRxiv - Cancer Biology 2021Quote: ... The endothelial monolayer was then incubated with human TNFα (10 ng/ml; PeproTech) for 16h ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human TGFβ and PDGF were obtained from Peprotech (Rocky Hill, CT, USA) and used at a final concentration of 5 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... 1ml of medium with 80 U/mL of recombinant human IL-2 (PeproTech) was added to the wells ...
-
bioRxiv - Cancer Biology 2020Quote: ... human PDGF-AA (10 ng/mL) and PDGF-BB (10 ng/mL) (Peprotech) and heparin (2 ng/mL ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Recombinant human TGFβ and PDGF were obtained from Peprotech (Rocky Hill, CT, USA) and used at a final concentration of 5 ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... and 25 ng/mL recombinant human IL-13 (PeproTech; Rock Hill, NJ, USA); M2b cells with 100 ng/mL LPS and 16.7 µL/mL immune complexes (IC ...
-
bioRxiv - Immunology 2020Quote: ... and 20 ng/mL recombinant human IFN-γ (PeproTech; Rock Hill, NJ, USA). Alternately M2 MΦs were activated as follows ...
-
bioRxiv - Immunology 2020Quote: ... while control mice received a molar equivalent of recombinant human IL-15 (Peprotech) in PBS ...
-
bioRxiv - Cancer Biology 2021Quote: ... 50 ng/ml recombinant human fms-related tyrosine kinase 3 ligand (rhFLT3L, Peprotech), 30 ng/ml rhIL-3 (all from Peprotech) ...
-
bioRxiv - Immunology 2022Quote: ... Macrophages were cultured in complete RPMI in presence of human M-CSF (Peprotech) and were used at day 7 post-differentiation.